GlassScriptPhysician profile
Steven C Napierkowski
NPI 1801143144
$11,974.20
in general payments reported to CMS, 2019-2025
41 companies · $1,434 in 2025
The $1,434 reported for 2025 was more than what 78% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,869 · 2020: $741 · 2021: $1,129 · 2022: $1,241 · 2023: $1,802 · 2024: $2,759 · 2025: $1,434.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,481 · Travel and Lodging: $1,415 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,480.67 |
| Travel and Lodging | $1,414.95 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,246.77 | 2019-2025 | Versacross Access Solution, Watchman Flx, Varithena Administration Pack |
| Astrazeneca Pharmaceuticals LP | $779.24 | 2019-2024 | Farxiga |
| Abbott Laboratories | $709.32 | 2019-2025 | Cardiomems, Confirm Rx |
| Medtronic Vascular, INC. | $697.32 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $602.96 | 2021-2025 | Verquvo, Capvaxive |
| Inari Medical, INC. | $551.49 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $471.16 | 2019-2025 | |
| Endologix LLC | $435.73 | 2023-2025 | Torus Stent Graft System, Endocross Device |
| Boehringer Ingelheim Pharmaceuticals, INC. | $407.45 | 2020-2025 | Jardiance |
| Amgen INC. | $394.20 | 2019-2025 | Repatha, Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $334.61 | 2019-2025 | Lifevest |
| Edwards Lifesciences Corporation | $321.72 | 2019-2025 | Sapien 3 Ultra Resilia, Pascal |
| Teleflex LLC | $285.56 | 2019-2024 | Guideliner, Supercross |
| Janssen Pharmaceuticals, INC | $246.75 | 2019-2024 | Xarelto |
| Medtronic, INC. | $246.62 | 2021-2025 | Symplicity G3, Cobalt Dr Mri Surescan, Linq II |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $242.46 | 2023-2025 | Opsumit, Uptravi |
| Esperion Therapeutics, INC. | $224.63 | 2020-2024 | Nexletol |
| Cardiovascular Systems INC. | $210.39 | 2019 | |
| Biotronik INC. | $194.38 | 2019-2021 | |
| Impulse Dynamics (USA) INC. | $178.11 | 2023 | Optimizer |
| Abiomed | $121.38 | 2021-2025 | Impella |
| Cashflow Solutions, LLC | $119.25 | 2023-2025 | Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White |
| Novo Nordisk INC | $113.69 | 2024-2025 | Rybelsus, Ozempic, Wegovy |
| Baxter Healthcare | $111.70 | 2023-2025 | Hillrom - Carnation Ambulatory Monitor |
| Lexicon Pharmaceuticals, INC. | $106.08 | 2023-2024 | Inpefa |
| E.R. Squibb & Sons, L.L.C. | $103.38 | 2021-2025 | Eliquis, Camzyos |
| Cardinal Health 200 LLC | $91.80 | 2019 | |
| Tactile Systems Technology INC | $60.68 | 2022-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| Pfizer INC. | $55.77 | 2022-2025 | |
| Bard Peripheral Vascular, INC. | $43.91 | 2021-2025 | Venclose Maven Catheter |
| Biosense Webster, INC. | $38.23 | 2023 | Carto 3 |
| Kiniksa Pharmaceuticals International, Plc | $37.85 | 2024 | Arcalyst |
| Kci USA, INC. | $27.43 | 2023 | V.A.C. Veraflo Cleanse Choice, Activ.A.C., Prevena |
| Alnylam Pharmaceuticals INC. | $27.13 | 2022 | |
| Astellas Pharma US INC | $24.88 | 2019 | |
| Kestra Medical Technology Services, INC. | $23.53 | 2024 | Assure Wcd |
| Cook Medical LLC | $21.41 | 2022 | |
| Chiesi USA, INC. | $18.30 | 2022 | |
| Amicus Therapeutics, INC. | $16.24 | 2021 | |
| Scpharmaceuticals INC. | $16.11 | 2023 | |
| Azurity Pharmaceuticals, INC. | $14.58 | 2025 | Edarbi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Napierkowski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.